Business Description
Myomo Inc
NAICS : 334510
SIC : 3842
ISIN : US62857J1025
Description
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.75 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.33 | |||||
| Beneish M-Score | -3.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -34.1 | |||||
| 3-Year EBITDA Growth Rate | 57 | |||||
| 3-Year EPS without NRI Growth Rate | 56.9 | |||||
| 3-Year FCF Growth Rate | 57.2 | |||||
| 3-Year Book Growth Rate | -49.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 31.64 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.43 | |||||
| 9-Day RSI | 60.5 | |||||
| 14-Day RSI | 55.79 | |||||
| 6-1 Month Momentum % | 202.73 | |||||
| 12-1 Month Momentum % | 457.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.49 | |||||
| Quick Ratio | 2.16 | |||||
| Cash Ratio | 1.62 | |||||
| Days Inventory | 91.46 | |||||
| Days Sales Outstanding | 37.88 | |||||
| Days Payable | 54.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -80.8 | |||||
| Shareholder Yield % | -9.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.51 | |||||
| Operating Margin % | -42.78 | |||||
| Net Margin % | -42.34 | |||||
| FCF Margin % | -32.84 | |||||
| ROE % | -90.88 | |||||
| ROA % | -59.18 | |||||
| ROIC % | -210.23 | |||||
| ROC (Joel Greenblatt) % | -1003.29 | |||||
| ROCE % | -90.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.47 | |||||
| PB Ratio | 10.39 | |||||
| Price-to-Tangible-Book | 10.39 | |||||
| EV-to-EBIT | -10.83 | |||||
| EV-to-EBITDA | -11.56 | |||||
| EV-to-Forward-EBITDA | -14.62 | |||||
| EV-to-Revenue | 4.63 | |||||
| EV-to-Forward-Revenue | 3.43 | |||||
| EV-to-FCF | -14.11 | |||||
| Price-to-Net-Current-Asset-Value | 11.43 | |||||
| Price-to-Net-Cash | 28.58 | |||||
| Earnings Yield (Greenblatt) % | -9.23 | |||||
| FCF Yield % | -6.47 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers